Skip to Content
  • Title
    Company Group Chairman
  • Affiliation
    Johnson & Johnson
  • Age

Taubert is responsible for more than 30% of J&J’s $72 billion in revenue with her oversight of the health care titan’s pharma business in North America and Latin America. Expect the size of her operation to grow as J&J completes its $30 billion acquisition of bio­pharma company ­Actelion. Taubert advocated for the deal, which will add a sixth business unit to J&J’s pharma operations—this one focused on pulmonary hypertension. She also joined J&J’s management committee this year, upping her influence internally.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Personal Information

Previous Rank45

Company Financials (2016, or most recently completed fiscal year)

Revenues ($M)71,890
Profits ($M)16,540
Market Value as of 9/14/17 ($M)